Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA: data from the AVERT trial

H. Ahmad, J. Baker, Mikkel Østergaard, P. Emery, P. Durez, J. Ye, S. Banerjee, P. Conaghan

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume76
Issue numberSuppl 2
Pages (from-to)174
Number of pages1
ISSN0003-4967
Publication statusPublished - 2017

Cite this